!!Bruno Giros - Selected Publications
\\
180 peer-reviewed publications - Web of Science: 20,000 citations; Hf=66   –   Google scholar: 30,000 citations ; Hf=78,  i10=184 \\
\\
Apazoglou K, Farley S, Gorgievski V, Belzeaux R, Lopez JP., Grenier J, Ibrahim E, El Khoury M-A, Tse Y.C., Mongredien R, Barbé A, Antunes de Macedo CE, Jaworski W, Bochereau A, Orrico A, Isingrini E, Guinaudie C, Mikasova L, Louis F, Gautron S, Groc L, Massaad C, Yildirim F, Vialou V, Dumas S, Marti F, Mechawar N, Morice E, Wong TP, Caboche J, Turecki G, Giros B*, Tzavara ET*. Antidepressive effects of targeting Elk-1 signal transduction. Nature Medicine, 2018, 24, 591-597. (17 citations)(* Join last authors).\\
\\
Guma E, Rocchetti J, Devenyi GA, Tanti A, Mathieu A, Lerch J, Elgbeili G, Courcot B, Mechawar N, Chakravarty MM, Giros B. Regional brain volume changes following chronic antipsychotic administration are mediated by the dopamine D2 receptor. Neuroimage, 2018, 176, 226-238.  (16 citations)\\
\\
Isingrini E, Perret L, Rainer Q, Amilhon B, Guma E, Tanti A, Martin G, Robinson J, Moquin L, Marti F, Mechawar N, Williams S, Gratton A, Giros B. Resilience against chronic stress is mediated by noradrenergic regulation of dopamine neurons. Nature Neuroscience, 2016, 19, 560-563. (64 citations)\\
\\
Tzavara ET, Li DL, Moutsimilli L, Bisogno T, Marzo VD, Phebus LA, Nomikos GG, Giros B. Endocannabinoids Activate Transient Receptor Potential Vanilloid 1 Receptors to Reduce Hyperdopaminergia-Related Hyperactivity: Therapeutic Implications. Biological Psychiatry, 2006, 59, 508-515. (104 citations)\\
\\
Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg Ic, Soderstrom H, Giros B, Leboyer M, Gillberg C, & Bourgeron T; Paris Autism Research International Sibpair Study.. Mutations of the X-linked neuroligins HNL3 and HNL4X are associated with autism. 2003, Nature genetics, 34, 27-29. (1211 citations)\\
\\
Sagné C., Agulhon C., Ravassard P., Darmon M., Hamon M., El Mestikawy S., Gasnier B. & Giros B. Identification and characterisation of a lysosomal transporter for small neutral amino acids. 2001, Proc. Natl. Acad. Sci. USA, 98 :7206-7211. (156 citations)\\
\\
Jaber M., W.J. Koch, H. Rockman, B. Smith, R.A. Bond, K.K. Sulik, J. Ross Jr., R.J. Lefkowitz, M.G. Caron & B. Giros.  Essential role of ß-Adrenergic Receptor Kinase-1 in cardiac development and function. 1996, Proc. Natl. Acad. Sci. USA, 93, 12974-12979. (265 citations)\\
\\
Giros B., M. Jaber, S.R. Jones, R.M. Wightman & M.G. Caron. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.  1996, Nature, 379, 606-612. (1907 citations)\\
\\
Sokoloff P., B. Giros, M.P. Martres, M.L.Bouthenet & J.C. Schwartz. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature, 1990, 347,146-151. (2526 citations)\\
\\
Giros B., P. Sokoloff, M.P. Martres, J.F. Riou, J.L. Emorine & J.-C. Schwartz. Alternative splicing directs the expression of two D-2 dopamine receptor isoforms. Nature, 1989, 342, 923-926. (638 citations)